Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05114798 · ClinicalTrials.gov registry record · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
A NA study of Obesity and Colorectal Cancer, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 255
- Enrollment target
- 1
- Study location
NCT05114798: Recruiting NA study of Obesity and Colorectal Cancer, sponsored by University of Illinois at Chicago.
NCT05114798 is a NA study of Obesity and Colorectal Cancer that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 255 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05114798, a NA study of Obesity and Colorectal Cancer, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 255 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 42% of American adults are obese, and this condition is strongly related to the development of colorectal cancer. Innovative lifestyle strategies to treat obesity and reduce colorectal cancer risk are critically needed. This research will demonstrate that time-restricted eating, a type of intermittent fasting, is an effective therapy to help obese individuals reduce and control their body weight and prevent the development of colorectal cancer.
Primary Outcome
Body weight in kg
Conditions Studied
Interventions
- BEHAVIORAL Time restricted eating
- BEHAVIORAL Calorie Restriction
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2022-05-17 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT05114798 shows while recruiting
NCT05114798 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (69% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Time restricted eating is the first listed.
NCT05114798 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05114798 about?
NCT05114798 is a clinical study titled "Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers". Approximately 42% of American adults are obese, and this condition is strongly related to the development of colorectal cancer. Innovative lifestyle strategies to treat obesity and reduce colorectal cancer risk are critically needed. This research will demonstrate that time-restricted eating, a type...
What is the current status of trial NCT05114798?
This trial is currently recruiting. It is a NA study. The enrollment target is 255 participants. The study started on 2022-05-17. Estimated completion is 2027-08-31.
What conditions does trial NCT05114798 study?
This clinical trial studies the following conditions: Obesity, Colorectal Cancer, Weight Loss, Time-restricted Eating.
What interventions are being tested in trial NCT05114798?
The interventions under investigation include: Time restricted eating (BEHAVIORAL), Calorie Restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT05114798?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05114798 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05114798's enrollment target sits among peer trials
255 253rd of 1053 higher than 801 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
- NCT05616130 · 255 participants
Pathological Myeloid Activation After Sepsis and Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI